Support for the “2026 Kumamoto Earthquake”

Worth reading

37Immaterial

0–100. This measures how worthwhile something is to read, not how good or bad the company is.

Direction

Deterioration

Direction inferred from the company’s description.

Scale

10000000

Wording

Definitive

How definitive the wording is.

Subject Entity

Alfresa Holdings Corporation (the filing company) and the Group

Target Locations / Products

Kumamoto Prefecture, affected areas, pharmaceuticals and other products

Occurrence28 July 2026 (the date of the 2026 Kumamoto Earthquake)

This disclosure07/31/2026

Cause

The 2026 Kumamoto Earthquake, which occurred on 28 July 2026

Amount of Impact on Business Performance

Disaster relief donation of ¥10 million (accounting classification: Not disclosed)

Outlook

The Company will make every effort to ensure a stable supply of pharmaceuticals and other products in the affected areas.

Event that occurred
Item	Details
Event name	Support for the “2026 Kumamoto Earthquake”
Date of occurrence	28 July 2026 (the date of the 2026 Kumamoto Earthquake)
Subject Entity	Alfresa Holdings Corporation (the filing company) and the Group
Target Locations / Products	Kumamoto Prefecture, affected areas, pharmaceuticals and other products
Cause	The 2026 Kumamoto Earthquake, which occurred on 28 July 2026
Amount of Impact on Business Performance	Disaster relief donation of ¥10 million (accounting classification: Not disclosed)
Outlook	The Company will make every effort to ensure a stable supply of pharmaceuticals and other products in the affected areas.

Items this document does not state (18)

Date recognized / date notice receivedAccounting period in which recognizedImpact on Earnings ForecastType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To support those affected by the disaster and contribute to recovery and reconstruction in the affected areas. Ensuring a stable supply of pharmaceuticals and other products is also a social responsibility of the Group.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.

Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.

Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.